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This study was aimed to synthesize polymeric excipients with improved mucoadhesive, cohesive and in
situ-gelling properties to assure a prolonged retention time of dosage forms at a given target site, thereby
achieving an increased uptake and improved oral bioavailability of certain challenging therapeutic agents
such as peptides and proteins. Accordingly, poly(acrylic acid)-cysteine-2-mercaptonicotinic acid (PAA-
cys-2MNA) conjugates were synthesized by the oxidative SeS coupling of PAA-cys (100-, 250- and
450 kDa) with 2-mercaptonicotinic acid (2MNA). Unmodiﬁed PAAs, PAAs-cys (thiomers) and PAA-cys-
2MNA (100-, 250- and 450 kDa) conjugates were compressed into tablets to perform disintegration
tests, mucoadhesion studies and rheological measurements. Moreover, cytotoxicty of the polymers was
determined using Caco-2 cells. The resulting PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates dis-
played 113.5  12.7, 122.7  12.2 and 117.3  4.6 mmol/g of 2-mercaptonicotinic acid, respectively. Due to
the immobilization of 2MNA, the PAA-cys-2MNA (pre-activated thiomers) conjugates exhibit compara-
tively higher swelling properties and disintegration time to the corresponding unmodiﬁed and thiolated
polymers. On the rotating cylinder, tablets based on PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates
displayed 5.0-, 5.4- and 960-fold improved mucoadhesion time in comparison to the corresponding
unmodiﬁed PAAs. Results achieved from tensile studies were found in good agreement with the results
obtained by rotating cylinder method. The apparent viscosity of PAA-cys-2MNA (100-, 250- and 450 kDa)
conjugates was improved 1.6-, 2.5- and 206.2-fold, respectively, in comparison to the corresponding
unmodiﬁed PAAs. Moreover, pre-activated thiomers/mucin mixtures showed a time dependent increase
in viscosity up to 24 h, leading to 7.0-, 18.9- and 2678-fold increased viscosity in comparison to
unmodiﬁed PAAs (100-, 250- and 450 kDa), respectively. All polymers were found non-toxic over Caco-2
cells. Thus, on the basis of achieved results the pre-activated thiomers seem to represent a promising
generation of mucoadhesive polymers which are safe to use for prolonged residence time of drug
delivery systems to target various mucosa.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
The concept of mucoadhesion and/or mucoadhesive polymers
was emerged in pharmaceutical literature in the early 1980s as an
interesting approach for controlled drug delivery. Mucoadhesive
polymers are supposed to prolong drug action by increased contact
time and residence time of the dosage form at the mucus
membrane [1,2]. Extensive research efforts have been made in the
past in order to evaluate and enhance adhesive properties of the
existing natural polymers together with the development of novel
mucoadhesive drug delivery systems. This led to the possibility to
use mucoadhesive polymers to target several mucosal surfacesx: þ43 512 507 2933.
rnkop-Schnürch).
-NC-ND license.such as gastrointestinal, pulmonary, oropharyngeal, ocular, buccal,
nasal, vaginal and rectal [3]. However, the research on mucoadhe-
sives is still in its preliminary stage and further advances are
needed for successful transformation of the academic research into
commercial formulations.
Thiolated polymers (thiomers) belong to a unique generation of
mucoadhesive polymers that was introduced in pharmaceutical
literature in 1990s [4]. Unlike other mucoadhesive polymers,
thiomers are capable of forming covalent bonds with cysteine-rich
subdomains of mucus glycoproteins via thiol/disulﬁde exchange
reactions [5]. These covalent bonds are supposed to be stronger
than non- covalent interactions such as hydrogen bonds, van der
Waal’s forces and ionic interactions of polymer with anionic
substructures of the mucus layer [6]. Accordingly, thiomers in
comparison to corresponding unmodiﬁed polymers provide strong
adhesionwhich is sufﬁcient to guarantee the localization of dosage
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oral bioavailability is expected resulting in many cases in a reduced
dosing frequency and patient-compliance [7]. Thiomers exhibit
furthermore enzyme inhibitory, permeation enhancing and efﬂux
pump inhibitory properties [8]. Additionally, thiomers act as
protective shield for incorporated drugs especially for peptides and
proteins towards an enzymatic attack in the intestine [9]. Thus, all
the mentioned advantages render thiomers as a highly suitable
excipients for controlled drug delivery.
Apart from all these merits, thiomers are comparatively less
stable in particular in solutions and gels as they are subject of thiol
oxidation at pH  5 unless sealed under inert conditions. This too
early oxidation of thiol groups before getting into contact with the
mucus layer might deteriorate the interactions between thiomer
and mucus layer thereby resulting in reduced efﬁcacy of thiomers.
Under these circumstances, the use of pre-activated thiol groups
might be an interesting approach in order to enhance stability,
mucoadhesion and cohesive properties of thiomers.
Accordingly, the overall objective of this studywas to improve the
stability of thiol groups towards oxidation as well as to enhance the
mucoadhesive and cohesive properties of thiomers over a broader
pH range. The concept of the preactivation of thiol groups is adapted
from previous knowledge in covalent chromatography, where, for
instance, peptides and proteins are very effectively quantitatively
linked to thiol bearing resins, when they are pre-activated via pyridyl
substructures [10]. Accordingly, 2-mercaptonicotinic acid (2MNA)
was coupled to poly(acrylic) acid-cysteine (PAA-cys) conjugates via
disulﬁde bonds formation. 2-Mercaptonicotinic acid was preferred
over 2-pyridyl disulphide owing to the advantage of less toxic
leaving group [11]. The resulting PAA-cys-2MNA conjugates or so-
called pre-activated thiomers were characterized in terms of their
thiol content, disulﬁde bonds, swelling behaviour, disintegration
properties and increase in viscosity. Moreover, the inﬂuence of
immobilized disulﬁde bonds was also evaluated on the mucoadhe-
sive and cohesive properties of these preactivted thiomers.
2. Materials and methods
2.1. Materials
Poly(acrylic acid) (PAA) (100-, 250- and 450 kDa), 2-mercaptonicotinic acid
(2MNA), hydrogen peroxide, L-cysteine hydrochloride, crude gastric mucin
from porcine stomach (Type II), reduced glutathione (GSH) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDAC) were purchased from
SigmaeAldrich. Resazurin sodium salt powder was purchased from Acros Organic
NV. All other reagents used were of analytical grade.
2.2. Synthesis of poly(acrylic acid)-cysteine conjugates
PAA-cysteine conjugates (PAA-cys; 100-, 250- and 450 kDa) were synthesized by
the covalent attachment of cysteine to poly(acrylic acid) (PAA) according to
a method described previously [12]. Brieﬂy, one gram each of PAA (100-, 250- and
450 kDa) was hydrated separately in demineralized water and the pH value of the
PAA solutions was adjusted to 6 by the addition of 5 M NaOH. Then, EDAC in the ﬁnal
concentration of 200 mM was added in order to activate the carboxylic acid moieties
of each of the hydrated polymers. After 20 min of incubation under stirring at room
temperature, 1 g of L-cysteine HCl was added to each of the hydrated PAA solution
and the pH was adjusted to 6. Reaction mixtures were incubated for 3 h at room
temperature under stirring. Neutralized polymers PAA (100-, 250- and 450 kDa)
prepared in the same way as the PAA-cys conjugates but omitting EDAC during
coupling reaction were served as references.
2.3. Puriﬁcation
In order to eliminate unbound reacting species from the polymers, each of the
above reaction mixtures was dialyzed ﬁve times using Spectra/Por 3 membrane
(MWCO: 1200) at (low acidic) pHw 3 for 3 days in total at 10 C in the dark against
5 mM HCl, then two times against the same medium but containing 1% NaCl. Then
the samples were dialyzed exhaustively two times against 1 mM HCl. After dialysis
the pH of PAA-cysteine (100-, 250- and 450 kDa) conjugates was readjusted to 6.Thereafter, the dialyzed products were freeze-dried for 3 days at 80 C under
reduce pressure and stored at 4 C until use.
2.4. Synthesis of poly(acrylic acid)-cysteine-2-mercaptonicotinic acid
(100-, 250- and 450 kDa)
In order to get 2MNA modiﬁed polymers, 2MNA dimer (2,20-dithiodinicotinic
acid) was ﬁrst prepared by oxidation of 2MNAwith hydrogen peroxide under neutral
pH conditions. Brieﬂy, 4 g of 2MNA were accurately weighed and dispersed in 50 mL
of demineralized water by ultrasoncation. After 30 min, pH of the dispersed solution
was adjusted to 7 e 8 using 5 M NaOH and a slight yellowish clear solution was ob-
tained. An aliquot of 5.3 mL of hydrogen peroxide (30%, w/v) was added drop-wise
and pH was maintained at 8 e 9 till a colorless solution (2MNA dimer; 2,20-dithio-
dinicotinic acid) was obtained. The resulting colorless 2MNA dimer solution was
further stirred at room temperature for 1 h and diluted to ﬁnal volume of 100mL. One
gram each of PAA-cys (100-, 250- and 450 kDa) was hydrated separately in 100 mL of
demineralized water. An aliquot of 1 mL of 2MNA solution was added drop-wise to
each hydrated thiomer solution and pH was adjusted to 7e8 using 5 M NaOH. The
reaction mixtures were incubated for over night at room temperature under
continuous stirring. Each of the above three reaction mixtures were dialyzed using
Spectra/Por 3 membrane (MWCO: 1200) in 5 L of demineralized water for 3 days in
total at 10 C in the dark. Thereafter, the dialyzed products were freeze-dried for 3
days at 80 C under reduce pressure and stored at 4 C until use.
2.5. Determination of the thiol group content
The amount of thiol groups immobilized on the polymer conjugates was
determined spectrophotometrically using Ellman’s reagent as described previously.
L-Cysteine HCl was employed to establish calibration curve for all polymer conju-
gates [4].
2.6. Disulﬁde bond test
Disulﬁde bond test was performed ﬁrstly to quantify disulﬁde bonds [4] formed
due to oxidation during the thiolation process and secondly to quantify disulﬁde
bonds formed between thiomers and 2MNA.
2.7. Quantiﬁcation of conjugated 2-mercaptonicotinic acid
The amount of conjugated 2-mercaptonicotinic acid (2MNA) was determined
spectrophotometrically. Brieﬂy, 0.5 mg of each of the PAA-cys-2MNA (100-, 250- and
450 kDa) was hydrated in 0.05 M phosphate buffer (pH 6.8) with 2% reduced
glutathione. After 60 min of incubation at room temperature, absorbance of 300 mL
solution was measured at 354 nm 2MNA was employed to establish calibration
curve for all polymer conjugates.
2.8. Preparation of tablets
Lyophilized PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates, corresponding
PAAs-cys and the unmodiﬁed PAAs were compressed (Hanseaten Type EI, Hamburg,
Germany) into 30 mg (5.0-mm diameter, 1.2-mm thickness) ﬂat-faced tablets by
applying a constant compaction pressure of 10 kN during the preparation all tablets.
2.9. Hardness of polymer tablets
Hardness of the tablets based on PAA-cys-2MNA (100-, 250- and 450 kDa)
conjugates, corresponding PAAs-cys and the unmodiﬁed PAAs was determined
using a Schleuniger 2-E/205 tablet-hardness tester (Dr. K. Schleuniger and Co.,
Switzerland).
2.10. Evaluation of the swelling behaviour
The water absorbing capacity of PAA-cys-2MNA (100-, 250- and 450 kDa), cor-
responding thiomers and the unmodiﬁed polymers was determined in simulated
gastric ﬂuid (0.1 M HCl, pH 1.2) as well as in simulated intestinal ﬂuid (0.1 M phos-
phate buffer, pH 6.8) by a gravimetric method as described previously [13]. Brieﬂy,
polymer tablets were accurately weighed and ﬁxed on the tip of a needle by
applying a little force with thumb. The tablets were then placed in a beaker con-
taining either 50 ml of 0.1 M HCl or 0.1 M phosphate buffer at 37 C. At various time
intervals hydrated tablets on the needle were taken out of the incubation medium
and excess water was removed by gentle soaking with a tissue paper. The tablets
were weighed again and the amount (%) of water uptake was determined gravi-
metrically as follows:
Water uptake ð%Þ ¼ ðWt W0Þ
Wt
 100
Where,Wt is the weight of the swollen polymer at a given time andW0 is the weight
in the dry state.
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Disintegration behaviour of the tablets comprising PAA-cys-2MNA (100-, 250-
and 450 kDa), corresponding thiomers and the unmodiﬁed lyophilized polymers
was evaluated in 100 mM phosphate buffer pH 6.8 at 37  0.5 C with a disintegra-
tion test apparatus according to the European Pharmacopoeia. The oscillating
frequency was adjusted to 0.5 s1 [14].
2.12. In vitro mucoadhesion studies
2.12.1. Rotating cylinder method
The mucoadhesion time of PAA-cys-2MNA (100-, 250- and 450 kDa), corre-
sponding thiomers and the unmodiﬁed polymers was determined according to
a method as described previously [12]. Brieﬂy, freshly excised porcine intestine was
provided from a local slaughter house. After necessary cleaning, the combined
jejunum and ileum segment of intestine was cut into small pieces (approx. 12 cm2)
without any discrimination. The intestinal mucosawas then ﬁxed on a stainless steel
cylinder (diameter: 4.4 cm; height: 5.1 cm; apparatus 4-cylinder) using a cyn-
oacrylate adhesive glue (Henkel KGaA, Austria) and polymer tablets were attached
to it. The cylinders were placed in the dissolution apparatus according to the
European Pharmacopoeia containing 900 mL of 100 mM phosphate buffer pH 6.8 at
37  0.5 C. The fully immersed cylinders were agitated with 100 rpm. The
detachment of the test tablets was monitored during an observation period of 24 h.
2.12.2. Tensile studies
Tensile studieswere performed using excised porcine intestinalmucosa according
to a method as described previously [15]. Brieﬂy, polymer tablet was glued to
a stainless steel ﬂat disc (10 mm in diameteter), which was hung from a laboratory
stand with a nylon thread (15 cm). The porcine mucosa was ﬁxed to a glass platform
using a cyanoacrylate adhesive and was placed in a beaker ﬁlled with 100 mM phos-
phate buffer (pH 6.8). The beaker was placed on a balance, and then carefully raised by
a mobile platform until the mucus came in contact with the tablet. The contact was
determined when the nylon thread holding the tablet became bent. After 20 min
incubation at 25 C, the mucosawas pulled down from the tablet at a rate of 0.1 mm/s
by manual turning of regulating knob provided with the mobile platform. The regu-
lating knob was precisely marked and validated via length measurements to ensure
the exactdisplacementof 0.1mmateach turn. Datapointswere collected every second
by computer software (SartoCollect V 1.0; Satorius AG, Germany) linked to the balance
with integrated interface. Datawas transferred toEXCEL 2007 (Microsoft, USA) and the
force versus displacement curves were analyzed to calculate the maximum force of
detachment (MDF) and the total work of adhesion as the area under the curve (AUC) in
accordance with the trapezoidal rule.
2.13. Cytotoxicity screening-resazurin assay
Resazurin assay was performed on Caco-2 cells to determine the in-vitro cyto-
toxicity of the polymers. Brieﬂy, Caco-2 cells (d¼ 1105 cells/well) were cultured in
a 24-well plate in a ﬁnal volume of 0.5 mLMEM (pH 7.4) and incubated at 37 C in 5%
CO2 environment. The medium was replaced with fresh medium every second day.
After 2 weeks, the cultured cells were washed twice with 1x PBS (pre-warmed at
37 C). Test solutions (0.5%; m/v), negative control (MEM with out phenol red) and
positive control (4% (v/v) Titron X-100) were added in triplicate to the cell culture in
0.5 mL quantity. The cells with medium were incubated again at 37 C in 5% CO2
environment for 3-, 24- or 72 h, respectively. After incubation solutions were
removed and cells were washed twice with 1x PBS. An aliquot of 250 mL of a 2.2 mM
resazurin solution was added to each well and cells were incubated at 37 C in a 5%
CO2 for 3 h. The ﬂuorescence of the supernatant was measured at a wavelength of
540 nm with background subtraction at 590 nm with Tecan inﬁnite M200 spec-
trophotometer, Grödig, Austria [16].
2.14. Measurement of the apparent viscosity of polymers
PAA-cys-2MNA (100-, 250- and 450 kDa), corresponding thiomers and the
unmodiﬁed polymerswere hydrated in 0.1 M phosphate buffer pH 6.8 at 37 C to give
ﬁnal concentration of 2% (m/v). After an incubation of 30 min, aliquots of 1000 mL
were transferred to a cone-plate viscometer (RotoVisco RT20, Haake, Karlsruhe,
Germany) for rheological measurements. The apparent viscosity (h) was determined
at a shear rate of 50 s1.
2.15. Measurement of the apparent viscosity of polymer/mucin mixtures
Porcine gastric mucin (4 g) was hydrated in 25 ml of demineralized water under
continuous stirring at 4 C overnight. The mucin solution was adjusted to pH 6.8
with 1 M NaOH and diluted to a ﬁnal volume of 50mLwith 0.1 M phosphate buffer pH
6.8. The mucin stock solution (8% m/v) was stored at 4 C no longer than 24 h. PAA-
cys-2MNA (100-, 250- and 450 kDa), corresponding thiomers and the unmodiﬁed
polymers were hydrated in demineralized water to give a concentration of 4% (m/v).
The polymer solutions were added to an equal volume of mucin stock solution,
mixed with a spatula and the pH of the mixture was adjusted to 6.8 with 2 M NaOH.After incubation for 0.5 h, 6 h and 24 h at 37 C, 1 mL of polymer/mucin incubates
were transferred to a cone-plate viscometer (RotoVisco RT20, Haake GmbH, Karls-
ruhe, Germany) for rheological measurements. The apparent viscosity of the poly-
mer/mucin mixtures (h) was determined as described above [14].
2.16. Statistical data analysis
Statistical data analysis was performed using the student t-test with p < 0.05 as
the minimal level of signiﬁcance. All values were expressed as the means  S.D.
3. Results and discussion
3.1. Synthesis and characterization of thiolated polymers
Synthesis of poly(acrylic acid-cysteine (PAA-cys) has already been
described by our research group previously [12]. Brieﬂy, L-cysteine
was covalently attached to PAA (100-, 250- and 450 kDa) by the
formation of amide bonds between carboxylic acid groups of
respective PAAs and primary amino groups of L-cysteine. The
carboxylic acid moieties of PAAs were activated using EDAC prior to
the coupling reaction. Determination of the thiol groups attached to
the polymers by the Ellman’s test demonstrated that on average
18.671.81,15.73 4.40 and 16.82 2.19mmol of thiol groupswere
immobilized per mole of acrylic acidmonomer as in the case of PAA-
cys (100-, 250-, 450 kDa) conjugates, respectively. Inter and/or intra
molecular disulﬁde bondswere 1.47 0.39mmol per mole of acrylic
acid monomer as in the case of PAA-cys (100-, 250-, 450 kDa)
conjugates, respectively. The low percentage of disulﬁde bonds
indicated low extent of oxidation during the coupling reaction thus
demonstrating efﬁciency of the thiolation step. The efﬁcacy of the
puriﬁcationmethod for the resulting PAA-cys conjugateswasveriﬁed
by controls which were prepared in exactly the same way but
omitting EDAC during the coupling reaction, exhibiting
4.00  2.00 mmol of thiol groups per gram of the control polymers.
The obtained polymers appeared as white, odourless powder of
ﬁbrous structure. For all experiments, the ﬁbrous structured lyophi-
lizates were used and no pulverization of the products was carried
out. The modiﬁed polymers were easily soluble in aqueous solution.
The lyophilized conjugates were stored at 4 C and found stable
towards air oxidation during the course of the study.
3.2. Synthesis and characterization of PAA-cys-2MNA
(100-, 250- and 450 kDa)
Synthesis of PAA-cys-2MNA (100-, 250- and 450 kDa) conju-
gates was achieved by coupling of PAA-cys (100-, 250-, and
450 kDa) to 2-mercaptonicotinic acid dimer (2,20-dithiodinicotinic
acid) via formation of disulﬁde bonds between thiol functions of
PAA-cys with thiol groups of 2MNA dimer. The presumptive
chemical substructure of PAA-cys-2MNA (100-, 250- and 450 kDa)
conjugates is illustrated in Fig. 1. The lyophilized PAA-cys-2MNA
conjugates were appeared as off-white powder of ﬁbrous struc-
ture, odourless and easily soluble in aqueous solution. The resulting
PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates were found to
exhibit 113.5  15.7, 122.7  12.2 and 117.3  14.6 mmol/g of 2-
mercaptonicotinic acid, respectively. Moreover, the inter- and/or
intramolecular disulﬁde bonds were found 160  40 mmol/g. This
increment in the percentage of disulﬁde bonds indicated efﬁciency
of oxidation in the presence of 2MNA dimer. Several methodologies
and different experimental systems are currently in practice for the
oxidative conversion of thiols to disulﬁdes. Some are rather time
consuming and associated with certain problems such as toxicity of
reagents, limited availability and instability of oxidizing agents,
require speciﬁc reaction conditions, formation of undesirable side
products and difﬁculties in product isolation [17e19]. These prob-
lems were avoided by the synthesis of 2MNA dimer. The proposed
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Fig. 1. Presumptive chemical substructure of poly(acrylic acid)-cysteine-2-
mercaptonicotinic acid (PAA-cys-2MNA) conjugates. 2-Mercaptonicotinic acid
(2MNA) was covalently coupled to poly(acrylic acid)-cysteine (PAA-cys) conjugates by
the oxidative SeS coupling of PAA-cys (100-, 250- and 450 kDa) with 2-
mercaptonicotinic acid (2MNA).
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seems to be based on: 1) the conversion of 2MNA into activated
oxidant form (2MNA dimer; 2,20-dithiodinicotinic acid) after
oxidation in the presence of hydrogen peroxide, 2) covalently
coupling of 2,20-dithiodinicotinic acid to free thiol (R1eSH) belongs
to poly(acrylic acid)-cysteine (PAA-Cys) conjugates and removal of
free 2MNAmolecule, 3) covalently coupling of remaining free thiols
(R2eSH) belongs to PAA-Cys to the free 2MNA molecule.3.3. Hardness of polymer tablets
A certain extend of hardness (strength) is a prerequisite for
tablets to endure mechanical stress during its fabrication, pack-
aging and transportation. Moreover, tablet hardness is believed to
be an important parameter that inﬂuences disintegration, swelling
and release properties [20]. Therefore, hardness of the tablets based
on PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates, corre-
sponding thiomers and unmodiﬁed polymers was determined.
Results are reported in Table 1 indicating that the hardness of the
tablets was found to be increases by increasing the average
molecular weight of the polymer. Moreover, tablets based on
unmodiﬁed, thiolated and pre-activated thiomers showed different
hardness although the same force (10 kN) was applied to compress
these tablets. For instance, covalent attachment of cysteine to PAAs
(100-, 250- and 450 kDa) considerably enhanced the crosslinkingTable 1
Comparison of the total work of adhesion (TWA), maximum detachment force (MDF) a
30 mg tablets consisting of PAA-cysteine (100-, 250- and 450 kDa) and PAA-cys-2MNA
Indicated values are mean  S.D. of at least three experiments.
Tested polymers TWA (mJ) I
r
unmodiﬁed PAA (100 kDa) 25.7  3.0 e
PAA-cysteine (100 kDa) 75.4  9.5 2
PAA-cysteine-2MNA (100 kDa) 152.2  44.3 5
unmodiﬁed PAA (250 kDa) 47.3  7.9 e
PAA-cysteine (250 kDa) 98.5  3.9 2
PAA-cysteine-2MNA (250 kDa) 189.5  7.5 4
unmodiﬁed PAA (450 kDa) 106.9  13.2 e
PAA-cysteine (450 kDa) 202.2  24.3 1
PAA-cysteine-2MNA (450 kDa) 325.7  36.6 3properties and the hardness of the tablets was increased 2.1-, 2.4-
and 1.2- fold, respectively. A more pronounced effect was even
observed in the presence of pre-activated thiomers i.e. PAA-cys-
2MNA (100-, 250- and 450 kDa) based tablets where the hard-
ness was improved 3.0-, 3.3- and 1.4-fold, respectively. These
observations might be explained by the particulate nature of 2MNA
together with higher degree of inter- and/or intramolecular disul-
ﬁde bonds within PAA-cys-2MNA (100-, 250- and 450 kDa)
conjugates being responsible for increased stability and hardness of
PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates.3.4. Swelling behaviour
The swelling behaviour of mucoadhesive polymers has a great
impact on their stability, release of embedded drugs, adhesive
properties and cohesiveness [21,22]. After attachment with the
mucus layer, mucoadhesive polymers swell up by initiating water
absorption from the underlying mucosal tissue via capillary action
and diffusion process which leads to a considerably strong adhe-
sion. In contrast, excessive water uptake results in over swelling,
constrained cohesive properties and resulted in the failure of
mucoadhesive bond between the polymer and the mucus
membrane [23]. Therefore, moderate swelling is necessary to avoid
overhydration and loss of adhesive properties before the delivery
system reaches the target. In order to evaluate swelling behaviour,
water uptake studies were carried out in 0.1 M HCl (pH 1.2) and 0.1 M
phosphate buffer (pH 6.8) at 37 C, respectively. Water uptake
studies were performed with 30 mg (5.0 - mm diameter) ﬂat-faced
tablets based on unmodiﬁed PAAs (100-, 250- and 450 kDa), PAA-
cys (100-, 250- and 450 kDa) and pre-activated thiomers i.e. PAA-
cys-2MNA (100-, 250- and 450 kDa) conjugates.Results are shown
in Fig. 2. Unmodiﬁed PAA (100-, 250- and 450 kDa) displayed poor
water uptake and tablets were completely dissolved and/or eroded
within 6-, 10- and 30 min, respectively (data not shown). The
swelling behaviour of tablets based on thiolated and pre-activated
polymers seem to be strongly dependent on the molecular mass
and pH. For instance, tablets based on high molecular mass
(450 kDa) polymers showed enhanced water absorbing capacity in
comparison to the tablets based on low molecular mass (100- and
250 kDa) polymers. Similarly, all tablets showed more weight gain
in the presence of 0.1 M phosphate buffer (pH 6.8). The presence of
comparatively higher quantity of ionic substructures within less
acidic polymers is supposed to be responsible for improved water
uptake at elevated pH. Furthermore, it was observed that the
covalent attachment of cysteine to PAAs (100-, 250- and 450 kDa)
signiﬁcantly enhanced the swelling properties as well as stability of
these polymers, leading to 4.7-/7.9-, 17.3-/23.3-/and 37.1-/109.7-
fold weight gain in the presence of 0.1 M HCl (pH 1.2) and 0.1 M
phosphate buffer (pH 6.8), respectively. A more pronounced effectnd improvement ratios (indicated polymer/corresponding unmodiﬁed polymer) of
(100-, 250- and 450 kDa) in comparison to corresponding unmodiﬁed polymers.
mprovement
atio
MDF (mN) Improvement
ratio
18.8  3.0 e
.9 102.1  6.4 5.4
.9 129.1  2.0 6.8
26.6  8.1 e
.1 111.6  6.3 4.2
.0 144.8  39.5 5.4
92.7  19.3 e
.9 131.1  2.0 1.4
.0 233.8  8.7 2.5
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Fig. 2. Swelling behaviour of A: PAA-cys (100 kDa) (-,,), PAA-cys-2MNA (100 kDa)
(:, 6); B: PAA-cys (250 kDa) (-,,), PAA-cys-2MNA (250 kDa) ((:, 6); C: PAA-cys
(450 kDa) (-, ,), PAA-cys-2MNA (450 kDa) (:, 6). Water uptake studies were
carried out in simulated gastric ﬂuid (0.1 M HCl, pH 1.2) (white symbols) as well as in
simulated intestinal ﬂuid (0.1 M phosphate buffer, pH 6.8) (black symbols) at 37 C. All
indicated values represent an average of at least three experiments (S.D.).
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Fig. 3. Comparison of the disintegration behaviour of unmodiﬁed, thiolated and pre-
activated poly acrylate tablets (30 mg) with an average molecular mass of A:
100 kDa; B: 250 kDa and C: 450 kDa. Studies were performed with a disintegration
apparatus according to the European Pharmacopoeia in 100 mM phosphate buffer pH
6.8 at 37 C. The indicated disintegration time represents an average of at least three
experiments (S.D.). A1 differs from A2 p ¼ 0.0024; B1 differs from B2 p ¼ 0.0002; C1
differs from C2 p ¼ 0.001.
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PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates where the
initial weight was improved 22.1-/41.8-, 31.1/43.2- and 98.3-/182.2-
fold, respectively. These observations might be explained by the
fact that lipophilic nature of 2MNA together with higher degree of
inter- and/or intramolecular disulﬁde bonds within PAA-cys-2MNA
(100-, 250- and 450 kDa) conjugates is responsible for increased
stability, cohesiveness and swelling capacity of PAA-cys-2MNA
(100-, 250- and 450 kDa) conjugates.
3.5. Disintegration studies
Disintegration studies revealed that disintegration time
increased with increasing molecular mass of the polymers as thedifference in disintegration time between unmodiﬁed, thiolated
and pre-activated polymers become more pronounced with
increasing molecular mass. Results are shown in Fig. 3. As expected,
tablets comprising unmodiﬁed PAA (100-, 250- and 450 kDa) were
completely disintegrated with in 8-, 12- and 55 min, respectively. It
can be seen that thiolation process greatly improves the cross-
linking properties of polymers. As reported earlier, tablets
comprising PAA-cysteine (100-, 250- and 450 kDa) in comparison
to the tablets comprising corresponding unmodiﬁed polymers
displayed 2.6-, 3.1- and 53.8-fold improved disintegration time
[14,15]. Moreover, the covalent attachment of 2-mercaptonicotinic
acid (2MNA) to PAAs-cys signiﬁcantly enhanced the swelling
properties and stability of these thiomers and 15-, 19.7- and 69.1-
fold prolonged disintegration times were achieved in the pres-
ence of PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates,
respectively. The results obtained from disintegration studies are in
accordance with the theory that formation of covalent bonds
J. Iqbal et al. / Biomaterials 33 (2012) 1528e1535 1533(disulﬁde bonds) within polymer structure resulted in enhanced
stability and cohesion [11]. Thus, it is believed that the lipophilic
nature of 2MNA in combination with inter- and/or intramolecular
disulﬁde bonds within PAA-cys-2MNA (100-, 250- and 450 kDa)
conjugates is responsible for increased stability and prolong
disintegration time.3.6. Cytotoxicity screening-resazurin assay
Caco-2 cells were incubated with PAA-cys-2MNA (100-, 250-
and 450 kDa), PAA-cys (100-, 250- and 450 kDa) and corresponding
unmodiﬁed PAAs either for 3-, 24- or 72 h in order to evaluate their
in-vitro cytotoxic effect. Results are shown in Fig. 4. Cell viability of
more than 90%, 85% and 75% in the presence of PAA-cys-2MNA
(100-, 250- and 450 kDa) after 3-, 24- and 72 h respectively, indi-
cating that these polymers are not at all harmful for the cells. All
polymers were tested in a ﬁnal concentration of (0.5%; m/v) as
concentrations higher than 0.5% (m/v) led to a too high viscosity of
the sample. Moreover, the chosen concentration allows comparing
cytotoxicity of the pre-activated polymers to that of well-
established thiomers.3.7. In vitro mucoadhesion studies
Mucoadhesion studies were performed in order to evaluate on
one hand the inﬂuence of covalent attachment of 2MNA to PAA-cys0
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Fig. 4. Cytotoxicity potential of poly(acrylic acid)-cysteine-2-mercaptonicotinic acid (PA
unmodiﬁed polymers. Cytotoxicity was tested on CaCo-2 cells using resazurin assay and exp(100-, 250- and 450 kDa) conjugates and on the other hand the
inﬂuence of molecular mass using two different test methods.
3.7.1. Rotating cylinder method
Adhesion studies were performed utilizing jejunum and ileum
sections of freshly excised porcine intestinal mucosa thereby
obtaining comparable results in both cases. The presence of
lymphoid aggregates (peyer’s patches) is not supposed to have any
inﬂuence on mucoadhesion, as the phenomenon of mucoadhesion
is believed to be based on the associative interections between
mucoahesive polymers and mucus gel layer. Results obtained by
rotating cylinder method are illustrated in Fig. 5. Adhesion studies
revealed that immobilization of thiol groups on PAA (100-, 250-
and 450- kDa) resulted in 1.7-, 2.5- and 452-fold improved
mucoadhesive properties, respectively. Furthermore, due to the
incorporation of hydrophobic ligand 2MNA to PAAs-cys polymeric
backbone, the mucoadhesive properties of these thiolated poly-
mers were signiﬁcantly improved. On the rotating cylinder, tablets
based on PAA-cys-2MNA (100-, 250- and 450 kDa) conjugates
displayed 5.0-, 5.4- and 960-fold improved mucoadhesion time in
comparison to the corresponding unmodiﬁed PAAs.
3.7.2. Tensile studies
Tensile studies were performed on porcine intestinal mucosa in
order to conﬁrm adhesion results obtained by rotating cylinder
method. Results being illustrated in Table 1 were found in good
agreement with the results obtained by rotating cylinder method.5
 %
m
/v
)
 k
D
a
 (
0
.5
 %
 m
/v
)
 P
A
A
 4
5
0
 k
D
a
 (
0
.5
 %
 m
/v
)
P
A
A
-c
y
s
 4
5
0
 k
D
a
 (
0
.5
%
m
/v
)
P
A
A
-c
y
s
-2
M
N
A
 4
5
0
k
D
a
 (
0
.5
 %
 m
/v
)
p
o
s
it
iv
e
 c
o
n
tr
o
l 
(t
it
r
o
n
 X
®
 1
0
0
)
after 3 h
after 24 h
after 72 h
A-cys-2MNA) conjugates in comparison to respective thiomers and corresponding
ressed in percent. Indicated values are the means of at least three experiments (S.D.).
A0
10
20
30
unmodified PAA 
(100 kDa)
      PAA-cys     
(100 kDa)
PAA-cys-2MNA 
(100 kDa)
ad
he
si
on
 ti
m
e 
[m
in
]
A2
A1
B
0
25
50
75
100
unmodified PAA
(250 kDa)
     PAA-cys     
(250 kDa)
PAA-cys-2MNA
(250 kDa)
ad
he
si
on
 ti
m
e 
[m
in
]
B1
B2
C
0
250
500
750
1000
unmodified PAA
(450 kDa)
    PAA-cys    
(450 kDa)
PAA-cys-2MNA
(450 kDa)
ad
he
si
on
 
tim
e 
[m
in
]
C1
C2
Fig. 5. Comparison of the mucoadhesive properties of unmodiﬁed, thiolated and pre-
activated poly acrylates with an average molecular mass of A: 100 kDa; B: 250 kDa and
C: 450 kDa as determined by the rotating cylinder method. Thirty milligrams polymer
tablets were attached to excised porcine intestinal mucosa, which was spanned on
a vertical cylinder rotated with 100 rpm in 100 mM phosphate buffer pH 6.8 at 37 C. The
indicated time of adhesion represents an average of at least three experiments (S.D.). A1
differs from A2 p ¼ 0.0023; B1 differs from B2 p ¼ 0.0067; C1 differs from C2 p ¼ 0.0145.
J. Iqbal et al. / Biomaterials 33 (2012) 1528e15351534In case of tensile studies the total work of adhesion (TWA) was
found in good correlation with the maximum detachment force
(MDF). Several factors are supposed to be responsible for enhanced
mucoadhesive property of PAA-cys-2MNA (100-, 250- and 450 kDa)Table 2
Comparison of the apparent viscocity (h) of PAA-cysteine (100-, 250- and 450 kDa) and PA
polymers. Indicated values are mean  S.D. of at least three experiments.
Tested polymers Apparent viscosity [h (mPas)]
Without mucin (a) W
At time point “0” A
unmodiﬁed PAA (100 kDa) 10  4
PAA-cysteine (100 kDa) 16  4
PAA-cysteine-2MNA (100 kDa) 50  10
unmodiﬁed PAA (250 kDa) 12  4
PAA-cysteine (250 kDa) 27  5
PAA-cysteine-2MNA (250 kDa) 80  10
unmodiﬁed PAA (450 kDa) 26  2
PAA-cysteine (450 kDa) 6020  281
PAA-cysteine-2MNA (450 kDa) 12860  400 3conjugates. For instance, more active thiol groups are available in
the form of disulﬁde bonds which can interact withmucus and lead
to high cohesiveness to the polymer carrier, presence of disulﬁde
bonds prevent early oxidation of thiol groups before coming into
contact with the mucus gel layer, incorporation of hydrophobic
ligand decreases the dispersive properties of polymeric backbone
thus provide more stability thereby resulting in a prolonged resi-
dence time of the dosage form to the mucosal membrane.
3.8. Measurement of the apparent viscosity of polymers
The viscosity of 2% (m/v) PAA-cys-2MNA (100-, 250- and
450 kDa), corresponding thiomers and the respective unmodiﬁed
PAAs in 100 mM phosphate buffer (pH 6.8) was measured in order
to conﬁrm the results obtained from disintegration studies. Results
are shown in Table 2 (a). Unmodiﬁed control PAAs exhibit least
apparent viscosity due to the lack of ability to form intramolecular
bonds. In contrast, PAA-cys (100-, 250 and 450 kDa) conjugates due
to their ability to form intramolecular disulﬁde bonds at physio-
logical pH, led to enhanced apparent viscosity up to 1.6-, 2.5- and
206.2- fold, respectively. This increase was found even more
signiﬁcant in the presence of pre-activated PAA-cys-2MNA (100-,
250- and 450 kDa) conjugates where the improvement in apparent
viscosity was 5.0-, 7.2- and 477-fold, respectively. Hence, the ach-
ieved results conﬁrmed the hypotheses that increase in viscosity
proportionally correlates with the molecular mass and amount of
sulfhydryl moieties on the polymer [15].
3.9. Measurement of the apparent viscosity of polymer/mucin
mixtures
The apparent viscosity of polymer/mucin blend is supposed to be
a resultant of certain associations such as chain entanglements,
conformational changes and non-covalent interactions. The same
properties are believed to be responsible for the mucoadhesion
phenomenon, as well. Thus, viscosity measurements can be used as
an index to evaluate mucoadhesive bond strength [24,25]. Accord-
ingly, the apparent viscosities of PAA-cys-2MNA (100-, 250- and
450 kDa), corresponding thiomers and the corresponding unmod-
iﬁed PAAs were determined in the presence of mucin at pre-
determined time intervals. Results are shown in Table 2 (b). Viscosity
measurements were done in the presence commercially available
mucin instead of natural mucin in order to achieve better repro-
ducibility and comparability [14]. As anticipated, polymers with
higher molecular mass exhibit higher viscosity. Unmodiﬁed PAAs
were found to have no interactionwithmucin as their viscosity was
remain constant over a time period of 24 h. PAA-cys (100-, 250- and
450 kDa) showed time dependent increase in viscosity due to
associative interactions with mucus glycoproteins and gradualA-cys-2MNA (100-, 250- and 450 kDa) in comparison to corresponding unmodiﬁed
ith mucin (b)
fter 0.5 h After 6 h After 24 h
10  4 10  2 10  2
20  5 20  2 30  5
50  10 55  10 70  10
24  2 23  3 23  4
50  30 70  10 140  30
287  49 318  69 434  69
63  10 61  2 62  2
7982  405 17027  719 19458  1852
5870  1942 58872  3227 166033  24017
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thiomers i.e. PAA-cys-2MNA (100-, 250- and 450 kDa) displayed
a more pronounced time dependent increase in viscosity in
comparison to respective PAA-cys and corresponding unmodiﬁed
PAA. The increase is most likely due to the efﬁcient physico-
chemical interactions between the mucin and the PAA-cys-2MNA
(100-, 250- or 450 kDa) resulting in 7.0-, 18.9- and 2678-fold
enhanced viscosity in comparison to unmodiﬁed PAAs, respectively.
It is believed that the pre-activated thiomers can interact with
mucin glycoproteins in many different ways resulting in very high
viscosity of pre-activated polymer/mucin blends. Preactivated
thiomers contain hydroxyl groups in their structure which can
easily undergo a nucleophilic attack on the carbonyl group of
aspartic acid and glutamic acid substructures of mucus, resulting
in the formation of stable ester bonds. Preactivated thiomers also
contain electronegative nitrogen atoms which are able to interact
with nitrogen atoms of proline substructures in mucin. Addition-
ally, nitrogen atom (acceptor) of precativated thiomers can
interact with the oxygen atom (donor) of the carbonyl group
containing asparagine and glutamine. Another possible interaction
is the bond formation between the oxygen atom of the carbonyl
group (acceptor) of the pre-activated thiomer and the nitrogen
atom of the proline substructures (donor) of mucin. Furthermore,
carboxylic groups of pre-activated thiomers can interact with
carboxyl groups of aspartic acid and glutamic acid substructures in
mucin via formation of hydrogen bond. Last but not least, pre-
activated thiomers contain free thiol groups in addition with
disulﬁde bonds which can interact with cysteine-rich subdomains
found in mucin leading to the formation of new disulﬁde bonds
[5,14]. Mucus is composed of numerous cationic charged
substructures like arginine and lysine [26], the formation of
disulﬁde bonds with thiol groups neighboured by an anionic
charged carboxyl group like it is the case for the pre-activated
PAA-cys-2MNA conjugates is highly promoted. Overall, the
process of formation of new bonds between pre-activated poly-
mers and mucus, is supposed to be responsible for the strength-
ening of mucoadhesive bond and time-dependent changes in
viscosity of polymer/mucin mixtures.4. Conclusion
This study summarizes the synthesis and characterization of
pre-activated poly(acrylic acid)-cysteine-2MNA (100-, 250-, and
450 kDa). The covalent attachment of 2MNA to poly(acrylic acid)-
cysteine back bone signiﬁcantly improved the mucoadhesion,
cohesion, stability and self crosslinking properties of these poly-
mers. Moreover, all the tested polymers were found non-toxic over
Caco-2 cells. Among all polymers tested, poly(acrylic acid)-
cysteine-2MNA (450 kDa) displayed the strongest mucoadhesive
properties followed by poly(acrylic acid)-cysteine-2MNA (250 kDa)
and poly(acrylic acid)-cysteine-2MNA (100 kDa). In contrast to so
far used thiomers, the pre-activated version contains disulﬁde
bonds which are unable to further oxidize at high pH. All these
properties represent pre-activated polymers as promising genera-
tion of mucoadhesive polymers which are safe to use for prolong
residence time of drug delivery systems to target various mucosal
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